NEW

Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System

Aerobiotix Inc., a manufacturer of air treatment devices for hospitals and health care, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Aerocure-MD medical air purification system.

AAAHC Releases Updated Toolkit Outlining Ambulatory Procedure Considerations for Obese Patients

To help ASCs implement necessary precautions and prevent negative outcomes for obese patients, the Accreditation Association for Ambulatory Health Care (AAAHC) has published a fully revised Ambulatory Procedure Considerations for Obese Patients Toolkit.

FDA Updates Information on Respirator Decontamination Systems

The U.S. Food and Drug Administration (FDA) is reissuing the Emergency Use Authorizations for decontamination systems that are authorized to decontaminate compatible N95 respirators for use by healthcare personnel (HCP) to prevent exposure to pathogenic biological...

First Patient Treated in Clinical Trial of BCL System

CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise, announced that the first patient has been treated in its U.S. pivotal trial of the Breast Cancer Locator (BCL) System at Massachusetts General Hospital.

ExacTrac with Versa HD Reaches Milestone

Brainlab and Elekta have announced the installation of the 50th fully integrated system at Southampton General Hospital, which consists of Elekta’s Versa HD linear accelerator and ExacTrac X-Ray, patient positioning and monitoring technology by Brainlab. Institutions are increasingly selecting this combined solution for the precise delivery of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).

“Integrating the treatment delivery potential of all our Versa HD systems with the imaging capabilities of ExacTrac provides our service with the advanced technology to deliver a safe and effective SRS program to our patients,” stated Claire Birch, Head of Radiotherapy Physics at Southampton General Hospital.

Versa HD is a versatile, multifunctional, high-definition dynamic stereotactic and conventional radiotherapy (RT) solution that removes traditional treatment constraints, offering the capability to deliver SRS and SBRT in routine, standard treatment slots, with end-to-end precision and accuracy.

ExacTrac adds the flexibility to image the patient at any couch or gantry angle either prior to or during treatment delivery, helping to ensure no planning compromises need to be made due to in-room verification limitations. ExacTrac allows fast and reliable independent room-based imaging, creating a highly advanced frameless system that helps to assure the patient is adequately immobilized.

“The Versa HD and ExacTrac solution provides customers with a streamlined workflow that can simplify the complexities associated with stereotactic radiation delivery for individuals with cancer,” commented Claus Promberger, Director Product Definition at Brainlab. “This is due to its accuracy and the ability to efficiently detect and manage intra-fractional patient motion during treatment delivery.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X